指南与共识重症综合管理与镇静镇痛复苏、休克与脓毒症

V-A ECMO支持下的器官捐献:日本首两例的见解与建议

Organ donation under V-A ECMO support: insights and recommendations from Japan's first two cases.
指南 / 共识 · Resusc Plus · 2025-04-03
一句话结论日本首两例在V-A ECMO支持下完成法定脑死亡判定与器官捐献,未出现显著并发症,作者提出通过调节扫气流、优化EEG电极放置和Y形管路保障器官灌注的院内流程。

该文报告日本首两例在V-A ECMO支持下按日本法律标准完成脑死亡判定与器官捐献的病例,每例均经多学科协作和个体化临床规划。关键操作挑战包括通过控制性降低扫气流完成呼吸暂停试验、通过策略性技术调整减少EEG伪迹、以及术中规划确保器官灌注稳定。两例均成功完成且无显著并发症,作者据此制定了一套支持ECMO下安全、标准化脑死亡判定和器官获取的院内流程。作者认为,在特定条件下ECMO下脑死亡器官捐献可行,建立安全标准化的判定流程可能促进器官捐献并扩大可移植器官池。

要点

  • 日本首两例在V-A ECMO支持下按日本法律标准完成脑死亡判定与器官捐献,两例均成功完成且无显著并发症。
  • 呼吸暂停试验通过控制性降低扫气流完成,需优化扫气流以达到PaCO2目标。
  • EEG监测通过策略性设备放置减少伪迹,以支持脑死亡判定。
  • 通过将Y形管路整合入ECMO系统确保器官灌注有效。
  • 缺乏标准化流程带来挑战,尤其体现在延长呼吸暂停试验和优化器官灌注方面,但经多学科协作和细致规划克服。

适用人群与场景

  • 在V-A ECMO支持下行脑死亡判定与器官捐献的患者,依据日本法律标准,经多学科协作和个体化临床规划管理。

处置流程与药物剂量

  • 呼吸暂停试验通过控制性降低扫气流完成,并优化扫气流以达到PaCO2目标。
  • EEG监测通过策略性设备放置减少伪迹。
  • 通过将Y形管路整合入ECMO系统确保器官灌注有效。
  • 术中规划以确保器官灌注稳定。

研究设计与关键结果

  • 日本首两例在V-A ECMO支持下按日本法律标准完成脑死亡判定与器官捐献,两例均成功完成且无显著并发症。
  • 关键考虑包括优化扫气流以达到呼吸暂停试验期间的PaCO2目标、通过策略性设备放置减少EEG伪迹、以及通过将Y形管路整合入ECMO系统确保器官灌注有效。
  • 缺乏标准化流程带来挑战,尤其体现在管理延长呼吸暂停试验和优化器官灌注方面,但通过多学科协作和细致规划克服。

证据类型、等级与局限

  • 证据类型:病例报告(日本首两例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在特定条件下ECMO下脑死亡器官捐献可行,即使在应用有限的国家也可开展。
  • 作者认为,建立安全标准化的判定流程可能促进器官捐献并扩大可移植器官池。

指南或共识出处

  • Resusc Plus

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of veno-arterial extracorporeal membrane oxygenation (V-A ECMO) has expanded globally as a life-saving intervention of cardiac arrest. However, brain death following successful resuscitation presents unique clinical and procedural challenges, particularly in apnea testing, electroencephalographic (EEG) monitoring, and organ donation. Despite increasing international adoption of ECMO, standardized protocol for brain death determination under ECMO remain limited.

METHODS: This study describes Japan's first two cases of legal brain death determination and organ donation under V-A ECMO support, conducted in accordance with Japan's legal standards. Each case was managed through close multidisciplinary collaboration and tailored clinical planning. Key procedural challenges were addressed, including adaptation of apnea testing via controlled sweep gas flow reduction, minimization of EEG artifacts through strategic technical adjustments, and intraoperative planning to ensure stable organ perfusion. Based on these experiences, we developed an institutional protocol to support safe and standardized brain death determination and organ retrieval under ECMO.

RESULTS: Both cases were successfully completed without significant complications, offering valuable insights into ECMO-assisted organ donation. Key considerations included optimizing sweep gas flow to achieve PaCO2 targets during apnea testing, minimizing artifacts in EEG monitoring through strategic device placement, and ensuring effective organ perfusion by integrating a Y-shaped circuit into the ECMO system. While the absence of standardized protocols posed challenges, particularly in managing prolonged apnea testing and optimizing organ perfusion, these were overcome through robust multidisciplinary collaboration and meticulous planning.

CONCLUSION: This study suggests that brain death organ donation under ECMO can be performed under specific conditions, even in countries where its adoption has been limited. Establishing a safe and standardized determination process may enhance organ donation and expand the pool of transplantable organs.

来源:Resusc Plus,查看原文。版权归原作者所有。

参考来源

  1. Nagashima F, Matsui D, Hazama T, et al. Organ donation under V-A ECMO support: insights and recommendations from Japan's first two cases. Resusc Plus. 2025. PMID: 40291591. doi:10.1016/j.resplu.2025.100952

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。